Taipei Veterans General Hospital,

Slides:



Advertisements
Similar presentations
Zeroing in on Non-Small Cell Lung Cancer: Integrating Targeted Therapies into Practice.
Advertisements

Prognostic role of caveolin in breast cancer: A meta-analysis Ma X et al., Prognostic role of caveolin in breast cancer: A meta-analysis The Breast (2013)
HOXC6 and HOXC8 are potentially novel prognosis predictors of esophageal squamous cell carcinoma Keneng Chen, M.D., PhD, RCSF Luyan Shen, M.D., PhD 2015/4/28.
Changes in Tumor Growth and Metastatic Capacities of J82 Human Bladder Cancer Cells Suppressed by Down-regulation of Calreticulin Expression Speaker: Yi-Chien.
Insert Program or Hospital Logo Introduction Melanoma is notoriously resistant to chemotherapy. While surgical resection and adjuvant chemotherapy can.
Japanese Approach to colon cancer and the Outcome Dep. of Surgical Oncology Tokyo Medical and Dental University Kenichi Sugihara.
INCREASED EXPRESSION OF PROTEIN KINASE CK2  SUBUNIT IN HUMAN GASTRIC CARCINOMA Kai-Yuan Lin 1 and Yih-Huei Uen 1,2,3 1 Department of Medical Research,
Age, SexHistologyPredominant subtype Pathological stage EGFR mutation CAF1 61, MaleAdenocarcinoma Solid predominant pT3N2M0 L858R CAF2 71, MaleAdenocarcinoma.
Jo Anne Zujewski, MD Clinical Investigations Branch Cancer Therapy Evaluation Program Division of Cancer Diagnosis and Treatment May 2011 The Global Burden.
Cell Suicide in Health and Disease
Adjuvant and Neoadjuvant Therapy in Non- Small Cell Lung Cancer Seminars in Oncology 2oo5;32 (suppl 2):S9-S15 Kyung Hee Medical Center Department of Thoracic.
Association of Family History with Cancer Recurrence and Survival in Patients with Gastric Cancer Journal of Clinical Oncology : R2 Hwang.
The role of regulatory B cells on hepatocellular carcinoma progression Conclusion Results Fig2. (A and B) In vivo, Bregs in SCID mice increased the size.
Risk Stratification in Stage II Colon Cancer Patients Ramzi Amri, MD, PhD; Liliana G Bordeianou, MD, MPH; and David L Berger, MD Massachusetts General.
Preliminary data of Non- Small Cell Lung Cancer gene expression pilot study Tõnu Vooder, Kristjan Välk, Andres Metspalu Genoa 2005.
Prognostic analysis of surgical treatment of peripheral cholangiocarcinoma: Two decades of experience at Chang Gung Memorial Hospital Yi-Yin Jan, Chun-Nan.
Prognostic impact of Ki-67 in Croatian women with early breast cancer (single-institution prospective observational study) Ivan Bilić, Natalija Dedić Plavetić,
Differences in the Expression Profiles of Excision Repair Crosscomplementation Group 1, X-Ray Repair Crosscomplementation Group 1, and βIII-Tubulin Between.
Comparison between Pathologic Characteristics of Her2 Negative and Positive Breast Cancer in a Single Cancer Center in Jordan DR Majdi A. Al Soudi, MD,
高雄醫學大學附設醫院 外傷及重症外科 胃腸及一般外科
EXPRESSION OF ABERRANT p53 PROTEIN IN GASTRIC CANCER
Overexpression of β-Catenin and Cyclin D1 is Associated with Poor Overall Survival in Patients with Stage IA–IIA Squamous Cell Lung Cancer Irrespective.
Lung squamous cell carcinoma
Lipocalin 2 (LCN2) is a promising target for cholangiocarcinoma treatment and bile LCN2 level is a potential cholangiocarcinoma diagnostic marker Chun-Yi.
Yu-fang huang, yi-hui wu, cheng-yang chou*
Picture 3. Higher grade tumors are more frequently Ki67 positive
Volume 15, Pages (February 2017)
Prognosis of younger patients in non-small cell lung cancer
EMT inducing transcription factor SIP1: a predictive biomarker of colorectal cancer survival and recurrence? A Patel, R Sreekumar, R Bhome, KA Moutasim,
Elevated FOXC2 Expression Promotes Invasion of HCC Cell Lines and is Associated with Poor Prognosis in Hepatocellular Carcinoma Cell Physiol Biochem 2017;44:99–109.
PUBLISH ONLY Journal of Thoracic Oncology
A New Path Forward: Immune Checkpoint Inhibitors in Bladder Cancer
Department of Surgery, Taipei Veterans General Hospital Huang Kuo-Hung
2018/03/18 外科年會 Oral Presentation
Proposed Changes to the 7th Edition
Improved survival outcomes after resection of ductal adenocarcinoma in the body and tail of the pancreas: A single center 10 years’ experience Seong.
Expression of insulin-like growth factor II mRNA-binding protein 3 predicts early recurrence and poor prognosis in intrahepatic cholangiocarcinoma  Yu-Ling.
Characterization of Aurora A and Its Impact on the Effect of Cisplatin-Based Chemotherapy in Patients with Non–Small Cell Lung Cancer  Peng Kuang, Zuhua.
K. Lenhard Rudolph, Daniel Hartmann, Oliver G. Opitz  Gastroenterology 
A Japanese Lung Cancer Registry Study: Prognosis of 13,010 Resected Lung Cancers  Hisao Asamura, MD, Tomoyuki Goya, MD, Yoshihiko Koshiishi, MD, Yasunori.
UHRF1 is regulated by miR-9 in colorectal cancer
Prognostic Significance of TAZ Expression in Resected Non-Small Cell Lung Cancer  Mian Xie, MD, PhD, Li Zhang, MD, Chao-Sheng He, MD, Jin-Hui Hou, MD,
The 8th edition American Joint Committee on gastric cancer pathological staging classification performs well in a population with high proportion of.
Significance of P53 and Rb protein expression in surgically treated non-small cell lung cancers  Yung-Chie Lee, MD, PhD, Yih-Leong Chang, MD, Shi-Ping.
Molecular Therapy - Nucleic Acids
Combined Radiotherapy and Anti–PD-L1 Antibody Synergistically Enhances Antitumor Effect in Non–Small Cell Lung Cancer  Xiaomei Gong, MD, PhD, Xuefei Li,
Volume 24, Issue 1, Pages (January 2016)
Prognostic evaluation based on a new TNM staging system proposed by the International Association for the Study of Lung Cancer for resected non–small.
EIF4E Is an Adverse Prognostic Marker of Melanoma Patient Survival by Increasing Melanoma Cell Invasion  Shahram Khosravi, Kevin J. Tam, Gholamreza S.
Differences in the Expression Profiles of Excision Repair Crosscomplementation Group 1, X-Ray Repair Crosscomplementation Group 1, and βIII-Tubulin Between.
Detection of circulating tumor cells in patients with non–small cell lung cancer undergoing lobectomy by video-assisted thoracic surgery: A potential.
Prognosis and survival after resection for bronchogenic carcinoma based on the 1997 TNM-staging classification: the Japanese experience  Tsuguo Naruke,
Fas-associating death domain protein overexpression induces apoptosis in lung cancer cells  Peter K.M. Kim, MD, Sang-Youel Park, PhD, Patrick P Koty,
Iwao Takanami, MD, Ken Takeuchi, MD, Masatoshi Giga, MD 
Aberrant Wnt1/β-Catenin Expression is an Independent Poor Prognostic Marker of Non- small Cell Lung Cancer After Surgery  Xianhua Xu, MD, Ping-Li Sun,
Serum miR-16: A Potential Biomarker for Predicting Melanoma Prognosis
Refining esophageal cancer staging
Translated by Krishna Karamsetty
Volume 102, Issue 1, Pages 1-4 (July 2000)
PUBLISH ONLY Journal of Thoracic Oncology
High Expression of p300 Has an Unfavorable Impact on Survival in Resectable Esophageal Squamous Cell Carcinoma  Yong Li, MD, Hao-Xian Yang, MD, Rong-Zhen.
Apoptosis Cell Volume 108, Issue 2, Pages (January 2002)
Prognostic value of bronchiolo-alveolar carcinoma component of small lung adenocarcinoma  Masahiko Higashiyama, MD, Ken Kodama, MD, Hideoki Yokouchi,
Problems related to TNM staging: Patients with stage III non–small cell lung cancer  Kotaro Kameyama, MD, Cheng-long Huang, MD, Dage Liu, MD, Taku Okamoto,
Correlation of RSPO expression to LGR5 expansion in gastric cancer.
Cisplatin plus PTUPB decreases proliferation and angiogenesis but increases apoptosis as determined by immunohistochemical (IHC) analysis. Cisplatin plus.
FILM immunohistochemical protein signature is significantly associated with poor survival. FILM immunohistochemical protein signature is significantly.
Surgical resection of metachronous liver metastases
Influence of ASGR2 expression on survival.
Prognostic Significance of Tumor Size in Patients with Stage III Non–Small-Cell Lung Cancer: A Surveillance, Epidemiology, and End Results (SEER) Survey.
Presentation transcript:

Caspase 3 expression correlates with patient outcomes in gastric adenocarcinoma after gastrectomy Taipei Veterans General Hospital, Department of Surgery, Division of General Surgery National Yang-Ming University 黃國宏 楊慕華 方文良 吳秋文 石宜銘

Introduction Gastric cancer is the 5th most common cancer and 3nd leading cause of cancer related death worldwide International Journal of Cancer (GLOBOCAN 2012) 2015; 136:E359-386 p<0.001 stage IA (86.9%) stage IB (83.8%) stage IIA (75.8%) stage IIB (63%) stage IIIA (42.8%) stage IIIB (31.6%) stage IIIC (12.7%) stage IV (8.7%)

Introduction Caspase-3 (CASP3) is a major executioner protein of proteolytic degradation during apoptosis. Caspase-3 downregulation (CASP3/DR) in tumors frequently confers resistance to cancer therapy and is significantly correlated with a poor prognosis in cancer patients. The role of Caspase 3 in gastric cancer has not been investigated yet.

Caspase 3 Apoptosis can be initiated through one of two cell-signaling pathways. Both pathways converge on caspase-3, a protein that acts as the cell’s executioner. PAC-1 (Procaspase Activating Factor-1, see below) bypasses both pathways and initiates apoptosis by inducing procaspase-3 to cleave itself to yield active caspase-3.

Patients and Methods 366 gastric cancer patients after curative gastrectomy Using Immunohistochemical(IHC) stains. Clinicopathological appearances and survival data were analyzed. IHC score 0 : < 5 % positive cells, 1+: 5–25 % positive cells 2+:26–75 % positive cells 3+: >75 % positive cells

Panoremic Viewer

Positive and negative control

Immunohistochemical stains

-: 241 patients Results 1+: 84 patients 2+: 32 patients 3+: 9 patients Positive rate--34.2%

Overall survival

Disease free survival

AJCC TNM Stage Stage I Stage II Stage III

Discussion Our studies revealed that gastric cancer patients with Caspase 3 expression had better prognosis than those without. Caspase 3 could be a potential prognostic biomarker in gastric cancer patients who received curative surgery.

Discussion Caspase 3 expression is associated with better clinicopathological appearances and may act as a tumor suppressor in human gastric cancer. Further studies, such as in vitro and in vivo studies, are necessary to demonstrate the mechanism of Caspase 3 on the role of carcinogenesis in gastric cancer.

Thanks for your attention